KIR3DL2 and myeloid sarcoma: Studies have demonstrated that MS patients who express Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) on natural killer (NK) cells are more susceptible to HHV-6 infection [46,47,48].